全球左旋肉鹼市場 - 2023-2030年
市場調查報告書
商品編碼
1290411

全球左旋肉鹼市場 - 2023-2030年

Global L-Carnitine Market - 2023-2030

出版日期: | 出版商: DataM Intelligence | 英文 118 Pages | 商品交期: 約2個工作天內

價格

本網頁內容可能與最新版本有所差異。詳細情況請與我們聯繫。

簡介目錄

市場概況

全球左旋肉鹼市場在2022年達到2.124億美元,預計到2030年將見證有利可圖的成長,達到3.02億美元。在2023-2030年的預測期間,市場正以4.5%的複合年成長率成長。

由於擁抱健康生活方式的全球趨勢和生活方式相關疾病的日益流行,對左旋肉鹼的需求正在經歷一個重大的推動。消費者更加關注他們的飲食選擇,並積極尋找能夠幫助他們實現健康和健身目標的產品。因此,這為基於左旋肉鹼的產品創造了一個有利的市場環境。

由於消費者對健康和保健的認知提高,擴大採用健身程序,以及越來越重視體重管理等因素,左旋肉鹼市場預計將見證穩定成長。消費者正在積極尋求自然和有效的解決方案,以提高他們的整體健康水平,從而推動對左旋肉鹼補充劑和功能性食品的需求。

市場動態

採用健康生活方式的上升趨勢推動了市場的成長

採用健康生活方式的上升趨勢正在推動全球左旋肉鹼市場的發展。隨著越來越多的人把他們的整體健康放在首位,對能夠支持和提高健康生活方式的產品的需求也在成長。這種趨勢正在為左旋肉鹼創造一個有利的市場環境,左旋肉鹼是一種膳食補充劑,因其在促進能量代謝、體重管理和運動表現方面的潛在好處而聞名。

製造商正在投資於研究和開發,以開發有效、安全並符合消費者對天然和優質產品渴望的創新配方。例如,2022年9月13日,Modicare有限公司發布了關於推出Well Sports的公告。這一創新產品系列是為支持運動員和生活方式活躍的個人的健身目標而精心製作的。隨著這一產品的推出,Modicare有限公司涉足蓬勃發展的運動營養行業,進一步鞏固和擴大其在健康領域的地位。

左旋肉鹼製造技術和配方技術的進步推動市場成長

左旋肉鹼製造技術和配方技術的進步正在推動全球左旋肉鹼市場的發展。隨著科學研究和技術創新的不斷發展,製造和配製左旋肉鹼產品的新的和改進的方法正在被開發。這些進步正在為左旋肉鹼創造一個有利的市場環境,左旋肉鹼是一種以其潛在健康益處而聞名的膳食補充劑。

例如,2022年3月23日,Pro Nutrition & Fitness公司推出了一個創新的片劑產品系列,旨在提高整體能量水平,作為男性和女性的午夜脂肪燃燒器。新推出的補充劑,即'Pro Nutrition Multivitamin'和'Night Shred',為尋求改善其耐力、免疫力、能量水平、壓力管理和血壓控制的個人提供了全面的解決方案。

COVID-19影響分析

COVID-19大流行病對全球左旋肉鹼市場產生了重大影響。起初,由於供應鏈的中斷和消費者支出的減少,市場出現了下滑。然而,隨著大流行病的發展,市場見證了消費者行為向健康和保健產品的轉變,促使了左旋肉鹼的恢復和需求增加。市場通過關注電子商務管道和直接面對消費者的銷售來適應在封鎖期間接觸消費者。

人工智慧影響分析

人工智慧(AI)的整合對全球左旋肉鹼市場產生了深遠影響。人工智慧技術已經徹底改變了製造工藝,最佳化了生產效率,降低了成本。人工智慧驅動的分析增強了行銷策略,實現了有針對性的宣傳和個性化的產品推薦,推動了市場成長。人工智慧的數據驅動的洞察力提高了客戶的參與度和滿意度,促使客戶忠誠度的提高和重複購買。

目錄

第一章:方法和範圍

  • 研究方法
  • 報告的研究目標和範圍

第二章:定義和概述

第三章:執行摘要

  • 按等級抽樣調查
  • 按工藝分類的摘要
  • 按應用分類
  • 按地區分類

第四章:動態變化

  • 影響因素
    • 驅動因素
      • 消費者對健康和保健的認知不斷提高,推動了市場的成長。
    • 限制因素
      • L-肉鹼替代品的存在阻礙了市場的成長
    • 機會
      • 對體重管理和預防肥胖的重視程度上升,推動市場成長
    • 影響分析

第五章:行業分析

  • 波特五力分析
  • 供應鏈分析
  • 價格分析
  • 監管分析

第六章:COVID-19分析

  • COVID-19的分析
    • COVID-19之前的情況
    • COVID-19期間的情況
    • COVID-19之後的情況
  • 在COVID-19期間的定價動態
  • 需求-供應譜系
  • 大流行期間與市場有關的政府計劃
  • 製造商的戰略計劃
  • 結語

第7章:按等級分類

  • 食品
  • 醫藥
  • 飼料

第8章:按工藝分類

  • 化學合成
  • 生物工藝

第九章:按應用分類

  • 食品和飲料
  • 藥品
  • 動物飼料
  • 其他

第十章:按地區分類

  • 北美洲
    • 美國
    • 加拿大
    • 墨西哥
  • 歐洲
    • 德國
    • 英國
    • 法國
    • 義大利
    • 西班牙
    • 歐洲其他地區
  • 南美洲
    • 巴西
    • 阿根廷
    • 南美其他地區
  • 亞太地區
    • 中國
    • 印度
    • 日本
    • 澳大利亞
    • 亞太其他地區
  • 中東和非洲

第11章:競爭格局

  • 競爭格局
  • 市場定位/佔有率分析
  • 合併和收購分析

第十二章:公司簡介

  • Lonza
    • 公司概述
    • 產品組合和描述
    • 財務概況
    • 主要發展情況
  • Northeast Medicines Group Co., Ltd. (NEPG)
  • Biosint SpA
  • Cayman Chemical
  • Merck KGaA
  • Tokyo Chemical Industry Co., Ltd.
  • Ceva
  • Kaiyuan Hengtai Nutrition Co., Ltd.
  • ChengDa Medicines Co., Ltd.
  • Huanggang Huayang Medicines Co. Ltd.

第十三章:附錄

簡介目錄
Product Code: FB3812

Market Overview

The Global L-Carnitine Market reached US$ 212.4 million in 2022 and is projected to witness lucrative growth by reaching up to US$ 302 million by 2030. The market is growing at a CAGR of 4.5 % during the forecast period 2023-2030.

The demand for L-Carnitine is experiencing a significant boost due to the global trend of embracing a healthy lifestyle and the increasing prevalence of lifestyle-related diseases. Consumers are more mindful of their dietary choices and actively searching for products that can aid them in achieving their health and fitness goals. Consequently, this is creating a favorable market environment for L-Carnitine-based products.

The market for L-Carnitine is anticipated to witness steady growth as a result of factors such as heightened consumer awareness regarding health and wellness, the growing adoption of fitness routines, and an increased emphasis on weight management. Consumers are actively seeking natural and effective solutions to enhance their overall well-being, thereby driving the demand for L-Carnitine supplements and functional food products.

Market Dynamics

The Rising Trend of Adopting Healthy Lifestyles Drives the Market Growth

The rising trend of adopting healthy lifestyles is driving the global L-Carnitine market. As more individuals prioritize their overall well-being, there is a growing demand for products that can support and enhance a healthy lifestyle. This trend is creating a favorable market environment for L-Carnitine, a dietary supplement known for its potential benefits in promoting energy metabolism, weight management, and exercise performance.

Manufacturers are investing in research and development to develop innovative formulations that are effective, safe, and align with consumers' desires for natural and quality products. For instance, on September 13, 2022, Modicare Limited made an announcement regarding the introduction of Well Sports. This innovative product range is carefully crafted to support the fitness objectives of athletes and individuals leading an active lifestyle. With this launch, Modicare Limited ventures into the flourishing sports nutrition industry, further reinforcing and expanding its position in the wellness sector.

Advances in Manufacturing Technologies and Formulation Techniques of L-Carnitine Drive Market Growth

Advances in manufacturing technologies and formulation techniques of L-Carnitine are driving the global L-Carnitine market. As scientific research and technological innovations continue to evolve, new and improved methods for manufacturing and formulating L-Carnitine products are being developed. These advancements are creating a favorable market environment for L-Carnitine, a dietary supplement known for its potential health benefits.

For instance, on March 23, 2022, Pro Nutrition & Fitness launched an innovative line of tablet-based products aimed at enhancing overall energy levels and serving as a midnight fat burner for both men and women. The newly introduced supplements, namely 'Pro Nutrition Multivitamin' and 'Night Shred,' offer a comprehensive solution for individuals seeking to improve their stamina, immunity, energy levels, stress management, and blood pressure control.

COVID-19 Impact Analysis

The COVID-19 pandemic has significantly impacted the global L-carnitine market. Initially, the market experienced a downturn due to disruptions in supply chains and decreased consumer spending. However, as the pandemic progressed, the market witnessed a shift in consumer behavior toward health and wellness products, leading to recovery and increased demand for L-Carnitine. The market adapted by focusing on e-commerce channels and direct-to-consumer sales to reach consumers during lockdowns.

Artificial Intelligence Impact Analysis

The integration of artificial intelligence (AI) had a profound impact on the global L-Carnitine market. AI technologies have revolutionized manufacturing processes, optimizing production efficiency and reducing costs. AI-powered analytics have enhanced marketing strategies, enabling targeted campaigns and personalized product recommendations, driving the market growth. AI's data-driven insights have improved customer engagement and satisfaction, leading to increased customer loyalty and repeat purchases.

Segment Analysis

The global L-carnitine market is segmented based on grade, process, application, and region.

Increasing Adoption of Bioprocessing Technologies for the Production Of L-Carnitine

The bioprocess segment commands the largest share in the global L-Carnitine market. This dominance is a result of the significant adoption of bioprocessing technologies for the production of L-Carnitine. Bioprocesses, including fermentation and enzymatic conversions, are enabling efficient and scalable production of L-Carnitine, meeting the growing market demand. The use of bioprocesses ensures high purity, quality, and cost-effectiveness of L-carnitine production, making it the preferred method in the market.

For instance, on September 9, 2021, Fast&Up launched India's First Effervescent Carnitine. This delectable lemon-flavored L-Carnitine supplement stands out for its exceptional purity and high-quality L-Carnitine tartrate composition. Not only does it efficiently convert fat into energy, but it also actively promotes fat-burning and metabolism.

Geographical Analysis

The Strong Presence of Advanced Healthcare Systems in North America

The North America region exerts dominance over the global L-carnitine market, commanding a substantial market share. This is primarily due to the region's robust market infrastructure, advanced healthcare systems, and a significant focus on health and wellness. The presence of a large population of health-conscious consumers, coupled with a high disposable income, drives the demand for L-Carnitine-based products in North America. The region's well-established pharmaceutical and dietary supplement industries contribute to the market's growth by providing a wide range of L-Carnitine formulations and products.

Competitive Landscape

The major global L-carnitine market players include: Lonza, Northeast Medicines Group Co., Ltd. (NEPG), Biosint S.p.A., Cayman Chemical, Merck KGaA, Tokyo Chemical Industry Co., Ltd., Ceva, Kaiyuan Hengtai Nutrition Co., Ltd., ChengDa Medicines Co., Ltd., and Huanggang Huayang Medicines Co. Ltd.

Why Purchase the Report?

  • To visualize the global L-carnitine market segmentation based on grade, process, application, and region, a andderstand key commercial assets and players.
  • Identify commercial opportunities by analyzing trends and co-development.
  • Excel data sheet with numerous data points of L-carnitine market-level with all segments.
  • PDF report consists of a comprehensive analysis after exhaustive qualitative interviews and an in-depth study.
  • Product mapping available as Excel consisting of key products of all the major players.

The global L-carnitine market report would provide approximately 61 tables, 57 figures, and 118 pages.

Target Audience 2023

  • Manufacturers/ Buyers
  • Industry Investors/Investment Bankers
  • Research Professionals
  • Emerging Companies

Table of Contents

1. Methodology and Scope

  • 1.1. Research Methodology
  • 1.2. Research Objective and Scope of the Report

2. Definition and Overview

3. Executive Summary

  • 3.1. Snippet by Grade
  • 3.2. Snippet by Process
  • 3.3. Snippet by Application
  • 3.4. Snippet by Region

4. Dynamics

  • 4.1. Impacting Factors
    • 4.1.1. Drivers
      • 4.1.1.1. Increasing consumer awareness of health and wellness drives the market growth
    • 4.1.2. Restraints
      • 4.1.2.1. Availability of L-carnitine alternatives hamper the market growth
    • 4.1.3. Opportunity
      • 4.1.3.1. Rising emphasis on weight management and obesity prevention drives the market growth
    • 4.1.4. Impact Analysis

5. Industry Analysis

  • 5.1. Porters Five Force Analysis
  • 5.2. Supply Chain Analysis
  • 5.3. Pricing Analysis
  • 5.4. Regulatory Analysis

6. COVID-19 Analysis

  • 6.1. Analysis of COVID-19
    • 6.1.1. Scenario Before COVID-19
    • 6.1.2. Scenario During COVID-19
    • 6.1.3. Scenario Post COVID-19
  • 6.2. Pricing Dynamics Amid COVID-19
  • 6.3. Demand-Supply Spectrum
  • 6.4. Government Initiatives Related to the Market During Pandemic
  • 6.5. Manufacturers Strategic Initiatives
  • 6.6. Conclusion

7. By Grade

  • 7.1. Introduction
    • 7.1.1. Market Size Analysis and Y-o-Y Growth Analysis (%), By Grade
    • 7.1.2. Market Attractiveness Index, By Grade
  • 7.2. Food*
    • 7.2.1. Introduction
    • 7.2.2. Market Size Analysis and Y-o-Y Growth Analysis (%)
  • 7.3. Pharmaceutical
  • 7.4. Feed

8. By Process

  • 8.1. Introduction
    • 8.1.1. Market Size Analysis and Y-o-Y Growth Analysis (%), By Process
    • 8.1.2. Market Attractiveness Index, By Process
  • 8.2. Chemical Synthesis*
    • 8.2.1. Introduction
    • 8.2.2. Market Size Analysis and Y-o-Y Growth Analysis (%)
  • 8.3. Bioprocess

9. By Application

  • 9.1. Introduction
    • 9.1.1. Market Size Analysis and Y-o-Y Growth Analysis (%), By Application
    • 9.1.2. Market Attractiveness Index, By Application
  • 9.2. Food and Beverage*
    • 9.2.1. Introduction
    • 9.2.2. Market Size Analysis and Y-o-Y Growth Analysis (%)
  • 9.3. Pharmaceuticals
  • 9.4. Animal Feed
  • 9.5. Others

10. By Region

  • 10.1. Introduction
    • 10.1.1. Market Size Analysis and Y-o-Y Growth Analysis (%), By Region
    • 10.1.2. Market Attractiveness Index, By Region
  • 10.2. North America
    • 10.2.1. Introduction
    • 10.2.2. Key Region-Specific Dynamics
    • 10.2.3. Market Size Analysis and Y-o-Y Growth Analysis (%), By Grade
    • 10.2.4. Market Size Analysis and Y-o-Y Growth Analysis (%), By Process
    • 10.2.5. Market Size Analysis and Y-o-Y Growth Analysis (%), By Application
    • 10.2.6. Market Size Analysis and Y-o-Y Growth Analysis (%), By Country
      • 10.2.6.1. The U.S.
      • 10.2.6.2. Canada
      • 10.2.6.3. Mexico
  • 10.3. Europe
    • 10.3.1. Introduction
    • 10.3.2. Key Region-Specific Dynamics
    • 10.3.3. Market Size Analysis and Y-o-Y Growth Analysis (%), By Grade
    • 10.3.4. Market Size Analysis and Y-o-Y Growth Analysis (%), By Process
    • 10.3.5. Market Size Analysis and Y-o-Y Growth Analysis (%), By Application
    • 10.3.6. Market Size Analysis and Y-o-Y Growth Analysis (%), By Country
      • 10.3.6.1. Germany
      • 10.3.6.2. The UK
      • 10.3.6.3. France
      • 10.3.6.4. Italy
      • 10.3.6.5. Spain
      • 10.3.6.6. Rest of Europe
  • 10.4. South America
    • 10.4.1. Introduction
    • 10.4.2. Key Region-Specific Dynamics
    • 10.4.3. Market Size Analysis and Y-o-Y Growth Analysis (%), By Grade
    • 10.4.4. Market Size Analysis and Y-o-Y Growth Analysis (%), By Process
    • 10.4.5. Market Size Analysis and Y-o-Y Growth Analysis (%), By Application
    • 10.4.6. Market Size Analysis and Y-o-Y Growth Analysis (%), By Country
      • 10.4.6.1. Brazil
      • 10.4.6.2. Argentina
      • 10.4.6.3. Rest of South America
  • 10.5. Asia-Pacific
    • 10.5.1. Introduction
    • 10.5.2. Key Region-Specific Dynamics
    • 10.5.3. Market Size Analysis and Y-o-Y Growth Analysis (%), By Grade
    • 10.5.4. Market Size Analysis and Y-o-Y Growth Analysis (%), By Process
    • 10.5.5. Market Size Analysis and Y-o-Y Growth Analysis (%), By Application
    • 10.5.6. Market Size Analysis and Y-o-Y Growth Analysis (%), By Country
      • 10.5.6.1. China
      • 10.5.6.2. India
      • 10.5.6.3. Japan
      • 10.5.6.4. Australia
      • 10.5.6.5. Rest of Asia-Pacific
  • 10.6. Middle East and Africa
    • 10.6.1. Introduction
    • 10.6.2. Key Region-Specific Dynamics
    • 10.6.3. Market Size Analysis and Y-o-Y Growth Analysis (%), By Grade
    • 10.6.4. Market Size Analysis and Y-o-Y Growth Analysis (%), By Process
    • 10.6.5. Market Size Analysis and Y-o-Y Growth Analysis (%), By Application

11. Competitive Landscape

  • 11.1. Competitive Scenario
  • 11.2. Market Positioning/Share Analysis
  • 11.3. Mergers and Acquisitions Analysis

12. Company Profiles

  • 12.1. Lonza*
    • 12.1.1. Company Overview
    • 12.1.2. Product Portfolio and Description
    • 12.1.3. Financial Overview
    • 12.1.4. Key Developments
  • 12.2. Northeast Medicines Group Co., Ltd. (NEPG)
  • 12.3. Biosint S.p.A.
  • 12.4. Cayman Chemical
  • 12.5. Merck KGaA
  • 12.6. Tokyo Chemical Industry Co., Ltd.
  • 12.7. Ceva
  • 12.8. Kaiyuan Hengtai Nutrition Co., Ltd.
  • 12.9. ChengDa Medicines Co., Ltd.
  • 12.10. Huanggang Huayang Medicines Co. Ltd.

LIST NOT EXHAUSTIVE

13. Appendix

  • 13.1. About Us and Services
  • 13.2. Contact Us